Cardiovascular Risk and Bone Mineral Density in Children with Familial Mediterranean Fever: The Role of Disease Severity and Genetic Mutations
Authors:
- Emrah ÇığrıEmrah Çığrı
- Funda Çatan İnanFunda Çatan İnan
- Sedat GültenSedat Gülten
- Fethiye YildizFethiye Yildiz
- Mehmet Akif BildiriciMehmet Akif Bildirici
- Hilmi Onur KabukçuHilmi Onur Kabukçu
- Eren YildizEren Yildiz
- Metin AsilerenMetin Asileren
- Ayşe Ece GökkayaAyşe Ece Gökkaya
- Elif AksuElif Aksu
- Eren ErEren Er
Open Access
- 3 July 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (13) , 5970
Abstract
In the present study, cardiovascular risk indices (Atherogenic Index of Plasma [AIP], Atherogenic Coefficient [AC], Castelli Risk Index-1 [CRI-1], and Castelli Risk Index-2 [CRI-2]) and bone mineral density (BMD SDS) were evaluated in patients with Familial Mediterranean Fever (FMF), and the association of these parameters with disease severity and MEFV gene mutations was investigated. A total of 126 participants (96 FMF patients and 30 healthy controls) were included in the study. FMF patients were classified as mild, moderate, or severe according to the PRAS severity score. Cardiovascular risk indices, biochemical parameters of bone metabolism, and BMD SDS values were compared among the groups. The relationship between BMD SDS and atherogenic indices was assessed by Spearman correlation analysis. The results were also analyzed according to MEFV gene mutations. No significant difference was detected among the groups in terms of sex or age (p > 0.05). FMF patients were found to have substantially higher cardiovascular risk indices than the control group, and these indices increased in parallel with disease severity (p < 0.05). The BMD SDS value of the severe FMF group was significantly lower than that of the other groups (p = 0.025). No difference was detected among the groups with respect to bone metabolism parameters (p > 0.05). No significant correlation was observed between BMD SDS and cardiovascular risk indices (p > 0.05). M694V was the most frequently detected mutation, and the BMD SDS value was lower in patients carrying mutations other than M694V (p = 0.011). The increased cardiovascular risk in FMF patients is associated with disease severity. Severe disease is accompanied by a reduction in bone mineral density. The lack of an association between cardiovascular risk and bone mineral density suggests that these systems may be affected through different mechanisms. It is important that FMF patients are monitored with respect to cardiovascular and bone health.Keywords
All Related Versions
This publication has 38 references indexed in Scilit:
- Does Familial Mediterranean Fever Provoke Atherosclerosis in Children? Evaluation of Arterial Stiffness and Serum Endocan LevelsClinical Rheumatology, 2021
- Familial Mediterranean FeverLa Presse Médicale, 2019
- Familial Mediterranean fever, review of the literatureClinical Rheumatology, 2017
- Update on Bone Health in Pediatric Chronic DiseaseEndocrinology and Metabolism Clinics of North America, 2016
- Decreased bone mineral density in adult familial Mediterranean fever patients: a pilot studyClinical Rheumatology, 2008
- Bone mineral density in children with familial Mediterranean feverClinical Rheumatology, 2004
- Attainment of peak bone mass at the lumbar spine, femoral neck and radius in men and women: relative contributions of bone size and volumetric bone mineral densityOsteoporosis International, 2004
- The musculoskeletal manifestations of familial Mediterranean fever in children genetically diagnosed with the diseaseArthritis & Rheumatism, 2001
- Clinical differences between North African and Iraqi Jews with familial Mediterranean feverAmerican Journal of Medical Genetics, 1998
- The changing face of Familial Mediterranean FeverSeminars in Arthritis and Rheumatism, 1996